Tuesday, January 01, 2013 12:21:30 PM
On December 12, 2012, Foster City, California-based biopharmaceutical company Gilead Sciences and Canadian drug development company YM BioSciences announced that they have signed a definitive agreement under which Gilead will acquire YM for US$2.95 per share in cash, or approximately US$510 million. Wilson Sonsini Goodrich & Rosati advised Gilead in connection with the transaction.
The legal team is the real deal and now opened an office in Bejing, the Chinese Connection
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM